Larry Goldstein to Alzheimer Disease
This is a "connection" page, showing publications Larry Goldstein has written about Alzheimer Disease.
Connection Strength
1.026
-
Live discussion. From here to there: AbetaPP as an axonal transport receptor--how could this explain neurodegeneration in AD. 15 July 2002. J Alzheimers Dis. 2003 Dec; 5(6):483-9.
Score: 0.162
-
Rapid, scalable assay of amylin-ß amyloid co-aggregation in brain tissue and blood. J Biol Chem. 2023 05; 299(5):104682.
Score: 0.154
-
Aß efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas. Commun Biol. 2023 01 03; 6(1):2.
Score: 0.152
-
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol. J Alzheimers Dis. 2023; 96(2):683-693.
Score: 0.152
-
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report. Alzheimers Dement. 2022 06; 18(6):1109-1118.
Score: 0.139
-
Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease. Ann Neurol. 2020 03; 87(3):486.
Score: 0.124
-
Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-ß1-42 and Hypertension. J Alzheimers Dis. 2018; 66(3):1095-1104.
Score: 0.107
-
An assessment by the Statin Cognitive Safety Task Force: 2014 update. J Clin Lipidol. 2014 May-Jun; 8(3 Suppl):S5-16.
Score: 0.021
-
Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain. Stroke. 2010 Dec; 41(12):2744-9.
Score: 0.016